UNSPSC 51162346: Benzocaine/phenylephrine/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162346 Benzocaine/phenylephrine/phenylpropanolamine is a Commodity code under which state and local governments procure parenteral pharmaceutical products and ancillary medical supplies for correctional healthcare, public health emergency response, and community health programs. The Washington State Department of Corrections recently solicited parenteral products including total parenteral nutrition (TPN), peripheral parenteral nutrition (PPN), intravenous solutions, and controlled substances for eight correctional facilities across the state, while Seminole County, Florida sought naloxone and drug deactivation systems for community health initiatives. State and local issuing bodies under this code include state correctional departments and county health agencies. Both recent solicitations show emphasis on compliance with state business licensing, employee clearance requirements, and specified insurance coverage including commercial general liability and professional liability.

Washington State and Florida account for the recent documented activity under this code. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with a response deadline of October 7, 2026 at 4:00 PM PST and a pre-bid conference on September 23, 2026, seeking multiple award contracts across three geographic regions within the state, with initial contract performance running November 26, 2026 through June 30, 2030 and DOC retaining discretionary extension rights. The code shows state-level set-aside aspirations including small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) designations under Washington's Chapter 39.19 RCW. Seminole County issued IFB 60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the county's community health building and a contract term including an option for one-year renewal.